Supplementary Table 1 from Rethinking Multiple Myeloma Treatment: The Biological and Clinical Insights Guiding Immune-Based Combinations

2026 Open access

Read full text
Authors: Annamaria Gullà, Madhav V. Dhodapkar, Hermann Einsele, Marc Steffen Raab, Antonio Giovanni Solimando, Cirino Botta, Marcello Turi, Lilli Sophie Sester, Andrew Jay Portuguese, Torsten Steinbrunn, Kenneth Carl Anderson
DOI: 10.1158/2643-3230.31484137
Cited by: 0

Abstract

Supplementary table 1 shows the detection methods that have been developed to assess minimal residual disease (MRD) in multiple myeloma

Fields of Study & Subjects

Multiple Myeloma Research and Treatments Monoclonal and Polyclonal Antibodies Research Chronic Lymphocytic Leukemia Research

Publication details

Publication date
4 March 2026
Language
EN